Tag: childhood cancer awareness

The Pediatric Oncology Care Team: Every Role Explained

Posted on by Jennifer Glover

Key Takeaways:

  • Your child’s cancer care involves a full team, not a single doctor. A pediatric oncology care team typically includes oncologists, nurses, nurse practitioners, social workers, child life specialists, and other professionals who collaborate on every aspect of your child’s treatment and well-being.
  • Each team member serves a distinct purpose. From the oncologist directing the treatment plan to the child life specialist helping your child cope through play, every role exists to address a specific medical, emotional, or practical need.
  • Multidisciplinary care is linked to better outcomes. Research shows that children treated by coordinated, specialized teams at pediatric cancer centers have better survival rates and quality of life than those who receive fragmented care.
  • You are part of the team too. Parents and caregivers play an active role in their child’s care, and knowing who does what helps you ask the right questions and advocate effectively.

When your child is diagnosed with cancer, you’re suddenly surrounded by new faces — doctors, nurses, specialists, and support staff — each introducing themselves with titles you may have never heard before. It can feel overwhelming. But every person on your child’s care team is there for a reason, and understanding who they are and what they do can help you feel more grounded during one of the most disorienting experiences a family can face.

A pediatric oncology care team is a group of specialized healthcare professionals who work together to diagnose, treat, and support children with cancer. Unlike adult oncology, pediatric cancer care requires providers trained specifically in how cancer behaves in growing bodies and developing minds — and how to deliver treatment in ways that protect a child’s long-term health, development, and quality of life.

At Cure 4 The Kids Foundation, Nevada’s only dedicated outpatient pediatric cancer and rare disease treatment center, this team-based approach is built into every aspect of care. Here’s who you’ll meet and what they do.

Who Is On a Pediatric Oncology Care Team?

A pediatric oncology care team brings together medical, psychological, and supportive care professionals under one coordinated plan. While the exact team composition varies by center and diagnosis, most pediatric oncology programs include the following core roles.

Pediatric Oncologist (or Pediatric Hematologist-Oncologist)

The pediatric oncologist is typically the physician leading your child’s cancer treatment. These doctors have completed specialized fellowship training in childhood cancers and blood disorders, which means they understand how pediatric cancers differ biologically from adult cancers and how to select treatments — including chemotherapy, immunotherapy, and targeted therapies — that account for a child’s growth and development.

Your child’s oncologist directs the overall treatment plan, orders and interprets diagnostic tests, coordinates with other specialists, and monitors your child’s response to treatment over time. At Cure 4 The Kids Foundation, board-certified pediatric hematologist-oncologists lead every patient’s care.

Nurse Practitioner (NP) or Physician Assistant (PA)

Advanced practice providers — nurse practitioners and physician assistants — work alongside the oncologist as part of the primary care team. They conduct physical exams, help manage symptoms and side effects, adjust medications, order labs, and often serve as a consistent point of contact for families between physician visits. For many families, the NP or PA becomes one of the most familiar and trusted faces in the clinic.

Pediatric Oncology Nurses

Pediatric oncology nurses provide direct, day-to-day patient care. They administer chemotherapy and other medications, monitor vital signs, manage central lines and ports, educate families on home care procedures, and watch for complications. 

That said, the relationships they build with patients and families often make them one of the most trusted and familiar faces in the clinic. Research shows that oncology nurses are often among the first to notice signs of emotional distress in their patients — and that awareness is a critical part of the care chain, connecting families to the specialized behavioral health support they may need.

At Cure 4 The Kids Foundation, the nursing staff also specializes in complex and chronic infusion therapy, caring for patients whose treatments can range from a quick injection to a full-day infusion session.

Social Workers

Social workers are trained to address the practical and emotional challenges that come with a childhood cancer diagnosis. They conduct family needs assessments, connect families to community resources, help navigate insurance and financial assistance, provide therapeutic support, and intervene when safety concerns arise.

At Cure 4 The Kids Foundation, licensed social workers screen for family stressors, coordinate case management, and help assess patients who are transitioning to adult medical care, making sure no family faces these challenges alone.

Child Life Specialists

A certified child life specialist (CCLS) is a healthcare professional trained to help children understand and cope with the stress and anxiety of medical treatment. They use therapeutic play, age-appropriate education, and creative activities to help children process their diagnosis, prepare for procedures, and maintain a sense of normalcy during treatment.

For a 4-year-old, that might look like practicing with a cloth doll before a port access. For a teenager, it might mean having someone explain a treatment change in terms that respect their growing autonomy. Child life specialists also often provide support for siblings, who are often deeply affected by their brother’s or sister’s diagnosis.

At Cure 4 The Kids Foundation, child life specialists are on-site during infusions and treatments, bringing activities to the bedside and helping children find moments of comfort and even fun during long clinic days.

Clinical Neuropsychologist or Behavioral Health Provider

A cancer diagnosis affects more than the body. Clinical psychologists and behavioral health providers support the mental and emotional health of patients and their families throughout treatment. They screen for anxiety, depression, and trauma-related stress; provide coping strategies; and offer therapeutic interventions tailored to the developmental stage of the child.

Cure 4 The Kids Foundation’s Behavioral Health Department brings together neuropsychology, social work, and child life services under one coordinated program. The team participates in multidisciplinary case conferences, screens for safety risks, provides bereavement support, and ensures that psychological health is woven into every aspect of patient care.

Clinical Pharmacist

Clinical pharmacists play a critical behind-the-scenes role. They prepare and verify chemotherapy and other medications, calculate dosages appropriate for a child’s size and weight, monitor for drug interactions, and educate families on medication schedules and side effects. In pediatric oncology, where drug dosages must be precise and protocols are complex, the pharmacist is an essential safety check.

At Cure 4 The Kids Foundation, we have a pharmacy and pharmacists on-site so parents don’t have to travel to fill prescriptions for their kids somewhere else.

Radiologist and Imaging Technologist

Radiologists and imaging technologists use tools like X-rays, CT scans, MRIs, PET scans, and ultrasounds to help diagnose cancer, monitor tumor response, and guide treatment decisions. Some centers also have interventional radiologists who perform minimally invasive, image-guided procedures. These imaging specialists work closely with the oncology team to ensure the most accurate, up-to-date picture of your child’s condition.

Radiation Oncologist and Pediatric Surgeon

Depending on your child’s diagnosis and treatment plan, the care team may also include a radiation oncologist, who uses targeted radiation to shrink tumors and destroy cancer cells, and a pediatric surgeon, who performs biopsies, tumor removals, and other surgical procedures. Both of these specialists coordinate with the oncologist to time interventions for maximum effectiveness while minimizing impact on a child’s development. 

Laboratory Team

The laboratory team processes blood samples, biopsies, and other diagnostic specimens that guide treatment decisions. Cure 4 The Kids Foundation’s on-site CAP-accredited laboratory (accredited by the College of American Pathologists) ensures that diagnostic results meet the highest standards for accuracy and reliability — a distinction shared by a select group of laboratories nationwide.

On-Site Educator

Many pediatric cancer centers recognize that treatment can disrupt months or even years of a child’s education. Some centers, including Cure 4 The Kids Foundation, address this through on-site classroom partnerships. C4K collaborates with the Clark County School District to provide continuity of education during treatment, helping children keep up with their schoolwork so they can transition back to the classroom more smoothly when they’re ready.

Why Does a Team Approach Matter in Pediatric Cancer Care?

Childhood cancer is not one disease — it encompasses more than a dozen major types and many more subtypes, each with its own biology, treatment protocols, and long-term considerations. No single provider can address all of these dimensions alone.

Research consistently shows that multidisciplinary team care improves outcomes for children with cancer. That’s why the Children’s Oncology Group (COG), which includes member institutions like Cure 4 The Kids Foundation that treat approximately 90% of children diagnosed with cancer in the United States, has established formal guidelines requiring multidisciplinary teams as a standard of care.

The overall five-year survival rate for childhood cancers in the United States has risen from 63% in the mid-1970s to 87% between 2015 and 2021. That progress is the direct result of collaborative, team-based approaches to research and treatment.

How Can Parents Work Effectively With Their Child’s Care Team?

You are a member of your child’s care team. It’s completely normal to wonder what to do when your child is diagnosed with cancer. Here are some practical ways to engage:

Ask each new provider to explain their role. It’s completely appropriate to say, “Can you tell me what you do and how you’ll be involved in my child’s care?”

Keep a notebook or digital file with names, roles, and contact information for every provider. During treatment, you’ll interact with many different people, and having a reference helps you direct questions to the right person.

Don’t hesitate to ask your social worker or patient navigator for help with anything outside of medical treatment — transportation, financial assistance, school accommodations, or emotional support. That’s exactly what they’re there for.

And remember to always speak up when something doesn’t feel right. Your knowledge of your own child is irreplaceable, and care teams rely on parents to report changes in behavior, appetite, energy level, and pain.

Frequently Asked Questions About Pediatric Oncology Care Teams

The pediatric oncologist, also known as a pediatric hematologist-oncologist, typically leads the treatment plan and coordinates care among all other team members. This physician has specialized training in childhood cancers and blood disorders.

A child life specialist is a certified healthcare professional who helps children cope with the stress and anxiety of cancer treatment. They use therapeutic play, age-appropriate education, and creative activities to help children understand their diagnosis, prepare for medical procedures, and maintain developmental progress during treatment.

Children with cancer have complex medical, emotional, and developmental needs that no single provider can address alone. Multidisciplinary teams coordinate treatment across specialties, which research has linked to improved survival outcomes, fewer complications, and better long-term quality of life for patients.

Social workers in pediatric oncology help families navigate the practical and emotional challenges of a cancer diagnosis. This can include connecting families to financial assistance, providing therapeutic support, coordinating community resources, and conducting safety screenings.

Not necessarily. The specific composition of your child’s care team depends on their diagnosis, treatment plan, and individual needs. Your child’s oncologist will determine which specialists should be involved and when.

About the Author: Annette Logan-Parker brings over 30 years of experience in pediatric oncology to her role as Founder and Chief Advocacy & Innovation Officer at Cure 4 The Kids Foundation. She has dedicated her career to improving outcomes for children with cancer and ensuring equitable access to cutting-edge treatments for all families.

Why Families Trust Cure 4 The Kids Foundation for Pediatric Cancer Care

Posted on by Jennifer Glover

Key Takeaways:

  • Cure 4 The Kids Foundation is Nevada’s only dedicated pediatric cancer and rare disease treatment center, treating nearly 10,000 patients each year at its Las Vegas facility.
  • The organization has earned national recognition for more than two decades of innovation in pediatric oncology and rare disease care, including the 2026 Gamechanger Award presented by the U.S. Secretary of Health and Human Services and a Nevada State Senator.
  • Every child receives care regardless of ability to pay. Cure 4 The Kids Foundation’s Charity Care Program ensures no family is turned away for financial reasons.
  • Cure 4 The Kids Foundation employs 100% of Nevada’s board-certified pediatric oncologists, offering families access to the state’s deepest bench of childhood cancer specialists without leaving home.

When your child is diagnosed with cancer, one of the first and most urgent questions is: Where should we go for treatment? Families across Nevada and beyond turn to Cure 4 The Kids Foundation (C4K)—the state’s only dedicated pediatric cancer and rare disease treatment center—because of a track record built on clinical excellence, compassionate care, and nationally recognized innovation.

What Makes Cure 4 The Kids Foundation Different from Other Treatment Centers?

Most children’s hospitals have a pediatric oncology department. C4K was purpose-built—from the ground up—to focus exclusively on children with cancer and rare diseases. That single-minded focus shapes everything from staffing and research priorities to the way families experience care.

Founded in 2007 by Annette Logan-Parker, C4K began as a grassroots effort born from a deeply personal mission: ensuring that Nevada children facing life-threatening diagnoses could receive world-class treatment close to home. What started at a kitchen table has grown into a nationally recognized organization with more than 200 team members, Joint Commission accreditation, a CAP-accredited laboratory, and an expansive facility.

The result is a hybrid model that blends the clinical rigor of a major academic medical center with the heart of a nonprofit. C4K delivers research-focused, evidence-based care while maintaining a deeply human approach to supporting entire families—emotionally, practically, and financially.

Annette Logan-Parker holding the Gamechanger Award at the 2026 Starry Starry Night Gala recognizing Cure 4 The Kids Foundation for pediatric and rare disease innovation.

What National Recognition Has C4K Received?

C4K’s impact has been recognized at the highest levels of healthcare leadership. In January 2026, Founder Annette Logan-Parker received the Gamechanger Award at the Starry Starry Night Gala, held at Chaparral Country Club in Palm Desert, California. The award recognized more than two decades of leadership in pediatric and rare disease innovation and was presented by the U.S. Secretary of Health and Human Services and a Nevada State Senator representing part of Clark County (District 20), Jeff Stone.

This recognition builds on a history of honors that reflect C4K’s commitment to excellence, including being ranked #4 among the nation’s Best Nonprofits to Work For by NonProfit Times in 2021, recognition on the Inc. 5000 list of fastest-growing companies in America, and repeated Top Nevada Workplace designations.

These distinctions matter for families evaluating where to seek care. National recognition isn’t just a trophy on a shelf—it signals that an organization meets or exceeds the standards that define outstanding pediatric healthcare.

Why Does Specialized Pediatric Cancer Care Matter?

Children are not small adults. Their cancers behave differently, require different treatment protocols, and demand a care team that understands the unique needs of growing bodies and developing minds.

At C4K, families have access to Nevada’s board-certified pediatric oncologists—specialists whose entire careers are devoted to treating childhood cancer. This concentration of expertise means faster diagnoses, access to the latest clinical trials and research protocols, and treatment plans tailored specifically to pediatric patients.

Our clinical team includes pediatric oncologists and hematologists, behavioral health professionals, dedicated patient navigators, and more who help families manage everything from treatment schedules to insurance questions. It’s what we call “The C4K Way”—care that extends beyond medicine to support the whole family.

Will My Family Be Turned Away If We Can’t Afford Treatment?

No. One of the founding principles of Cure 4 The Kids Foundation is that no child with cancer will ever be denied treatment because of a family’s financial circumstances.

C4K’s Charity Care Program provides coverage for families who are uninsured, underinsured, or otherwise unable to pay for their child’s cancer or rare disease treatment. This commitment is central to our foundation’s mission and is reflected in our financial stewardship:

More than 90% of C4K’s expenses go directly to program services, meaning the vast majority of every dollar supports patient care.

For families navigating insurance questions, coverage gaps, or financial stress during a cancer diagnosis, C4K provides guidance and support from the very first appointment.

The Cure 4 The Kids Foundation Building at 1 Breakthrough Way in Las Vegas, Nevada

Where Is Cure 4 The Kids Foundation Located?

Cure 4 The Kids Foundation is located at 1 Breakthrough Way, Las Vegas, NV 89135, in the Summerlin area of Las Vegas. The facility is designed specifically for pediatric patients, with age-appropriate exam rooms, an onsite infusion center, and more.

C4K also serves families traveling from outside the Las Vegas area and out of state. As Nevada’s only dedicated pediatric cancer and rare disease treatment center, C4K regularly cares for patients whose families seek specialized expertise not available in their home community.

Frequently Asked Questions

Cure 4 The Kids Foundation is a nonprofit pediatric cancer and rare disease treatment center. It is an outpatient clinic, not a general hospital.

Yes. C4K accepts most major insurance plans. For families who are uninsured or underinsured, the Charity Care Program ensures that no child is turned away due to inability to pay.

Yes. C4K treats patients from across Nevada and beyond.

C4K treats the full spectrum of childhood cancers, as well as rare diseases and blood disorders. The clinical team includes specialists in pediatric oncology, hematology, rheumatology, and behavioral health.

Yes. C4K holds Joint Commission accreditation—the most rigorous quality and safety standard for medical facilities in the United States—and operates a CAP-accredited laboratory certified by the College of American Pathologists.

What to Do When Your Child is Diagnosed with Cancer

Posted on by Jennifer Glover

Key Takeaways:

  • Ask for a pediatric oncologist, not a general oncologist. Children are not small adults, and they need specialists trained specifically in childhood cancers.
  • Write down your questions before every appointment. Bring a notebook or a trusted person to help you remember what the care team tells you.
  • Seek a specialized pediatric cancer center with access to clinical trials, multidisciplinary care teams, and supportive services for the whole family.
  • You are not alone. Social workers, patient navigators, family support programs, and parent communities exist to help you through this—and you deserve that support.

When the Doctor Says “Cancer”

Nothing can prepare you for hearing that your child has cancer. In that moment, the world narrows to a single, terrifying word, and everything after it becomes a blur. You may not remember what the doctor said next. You may not know what questions to ask. You may feel frozen, panicked, or numb.

All of that is normal.

If you are reading this at 2 AM because your child was just diagnosed—or because you are waiting for test results and bracing yourself—this guide is for you. I wrote it to help you understand what happens next, what questions matter most, and how to find the specialized care your child deserves.

You do not need to absorb everything at once. Bookmark this page. Come back to it. Share it with your partner, a grandparent, or a friend who is helping you navigate this. The information will be here when you are ready.

What Are the First Steps After a Childhood Cancer Diagnosis?

The hours and days immediately after a diagnosis can feel chaotic. Here is what to focus on first.

1. Breathe. You Have More Time Than You Think.

Many childhood cancers, while urgent, do not require treatment within hours of diagnosis. You typically have several days—sometimes a week or more—to gather information, ask questions, and begin to make informed decisions. 

In fact, expert groups in pediatric oncology emphasize that a new diagnosis is overwhelming. Understanding all that is required from this point on is a process that will unfold for you over days and weeks, not just during one high-pressure conversation.

Your child’s medical team will let you know if your situation is an exception.

Right now, the most important thing you can do is be present for your child. They are watching you for cues about how to feel. You do not have to be strong. You just have to be there.

2. Make Sure You Have a Pediatric Oncologist

This is one of the most critical steps. A pediatric oncologist is a doctor who specializes exclusively in cancers that affect children and adolescents. Childhood cancers behave very differently from adult cancers—they respond to different treatments, grow at different rates, and require specialized protocols designed for developing bodies.

And, importantly, children with cancer who are treated at specialized, pediatric cancer centers have better survival outcomes than those treated in lower-volume or non specialty settings. 

So, if your child was diagnosed at a general hospital or by a family pediatrician, ask for a referral to a pediatric hematologist-oncologist at a specialized children’s cancer center. This is not about doubting your current doctor. It is about making sure your child has access to the specific expertise their diagnosis requires.

3. Start a Medical Binder and a Digital Folder

From this point forward, you will be receiving a ton of medical information: lab results, scan reports, treatment plans, medication lists, and care instructions. Start organizing it now.

A simple three-ring binder and folder on your phone and/or computer can make a big difference. Be sure to include sections for diagnosis details, treatment schedules, medication names and dosages, insurance information, and contact numbers for your care team. 

Many parents say this single step helped them feel more in control during an otherwise uncontrollable time.

What Questions Should I Ask My Child’s Oncologist?

You will have many appointments in the coming weeks for diagnostic tests, treatment planning, and care coordination. Having questions prepared helps you get the information you need and feel more active in your child’s care.

Here are the most important questions to ask early in the process:

About the Diagnosis

  1. What is the exact type and subtype of cancer my child has?
  2. What stage is the cancer, and what does that mean for my child specifically?
  3. Are additional tests or biopsies needed to confirm the diagnosis?
  4. Is this type of cancer common in children? What is the general prognosis?

About the Treatment Plan

  1. What treatment do you recommend, and why?
  2. What are the potential side effects—both short-term and long-term?
  3. How long will treatment last?
  4. Will my child need surgery, chemotherapy, radiation, or a combination?
  5. Are there clinical trials available for my child’s diagnosis?

About Daily Life During Treatment

  1. Can my child continue going to school? What accommodations might we need?
  2. What symptoms or side effects should prompt an emergency call or visit?
  3. Are there dietary changes or activity restrictions we should know about?
  4. What mental support services—social work, psychology, child life specialists—are available to us?

Do not worry about asking “too many” questions. Your child’s care team expects and welcomes them. If you think of questions between appointments, write them down so you do not forget.

What Should I Expect During My Child’s Cancer Treatment?

Every child’s treatment journey is unique, but understanding the general process can help reduce the fear of the unknown.

Diagnostic Phase

Before treatment begins, your child’s care team will run tests to determine the exact type, location, and extent of the cancer. This may include blood work, imaging scans such as CT, MRI, or PET scans, bone marrow biopsies, or surgical biopsies. This phase can feel like a difficult waiting period, but it is essential for developing the most effective treatment plan.

Treatment Planning

Once the diagnostic workup is complete, the oncologist will present a treatment plan. At a specialized pediatric cancer center, this plan is typically developed by a multidisciplinary team—a group of specialists that may include a pediatric oncologist, surgeon, radiation oncologist, pathologist, radiologist, social worker, psychologist, and child life specialist. This team approach ensures that every aspect of your child’s care is considered, from tumor biology to emotional well-being.

Active Treatment

Treatment may involve chemotherapy, surgery, radiation therapy, immunotherapy, targeted therapy, or some combination. The duration varies widely depending on the diagnosis—some treatment protocols last a few months, while others extend to two or three years.

During active treatment, your child may experience side effects like fatigue, nausea, hair loss, changes in appetite, or increased vulnerability to infections. Your care team will help you manage these side effects and will adjust the treatment plan as needed. Many children tolerate treatment better than parents expect, and your care team will work to maintain your child’s quality of life throughout.

Follow-Up and Survivorship

After treatment ends, your child will continue to see their oncologist for regular follow-up visits. These appointments monitor for any signs of recurrence and manage any long-term effects of treatment. Survivorship care is an important and ongoing part of your child’s journey, and a good pediatric cancer center will have programs specifically designed for childhood cancer survivors.

How Do I Find the Right Pediatric Cancer Specialist?

Not all cancer treatment centers are the same, and where your child receives care can make a meaningful difference in their experience and outcomes. Here is what to look for:

What Makes a Pediatric Cancer Center Different?

  • Board-certified pediatric oncologists who treat childhood cancers exclusively—not adult oncologists who occasionally see children
  • Multidisciplinary care teams that include specialists in surgery, radiology, pathology, psychology, social work, nutrition, and child life
  • Access to clinical trials, which give children the opportunity to receive the newest and most promising treatments
  • Family support services including financial counseling, social work, mental health support, and sibling programs
  • Child-friendly environments designed to reduce fear and support the emotional needs of young patients

Why Specialized Pediatric Care Matters

Children are not small adults. Their cancers are biologically different from adult cancers, and the treatments that work for adults do not always work for children—and vice versa. Pediatric oncologists complete specialized fellowship training focused specifically on childhood cancers, and they follow treatment protocols developed through decades of pediatric-specific research.

Additionally, children’s developing bodies respond differently to treatments like chemotherapy and radiation. A pediatric specialist understands how to balance effective cancer treatment with minimizing long-term impacts on growth, development, fertility, and organ function.

How Do I Take Care of Myself and My Family Right Now?

When your child is diagnosed with cancer, every instinct tells you to focus entirely on them. But your well-being matters too—not as an afterthought, but as an essential part of your child’s support system.

Let People Help

If friends or family offer to bring meals, drive your other children to school, or sit with you during appointments—let them. Many parents feel guilty accepting help, but the people in your life want to support you. Consider setting up a meal train, a shared calendar, or designating one person as the “point of contact” who can relay updates to your wider circle so you do not have to repeat difficult information over and over.

Seek Emotional Support

A childhood cancer diagnosis affects every member of the family. Many pediatric cancer centers offer counseling for parents, therapeutic support for siblings, and child life services to help your child cope with their treatment. You may also find comfort in connecting with other parents who are going through—or have been through—a similar experience. Ask your child’s care team about parent support groups, both in-person and online.

If you notice yourself feeling persistently overwhelmed, unable to sleep, or struggling to function, please reach out to a mental health professional. You are going through one of the hardest experiences a parent can face, and you deserve support too.

Talk to Your Child Honestly

Children are perceptive. Even very young children can sense when something is wrong, and the unknown is often more frightening than the truth. Work with your child’s care team to find age-appropriate ways to explain what is happening. Honesty, delivered with reassurance, helps children feel safe and builds trust during a time when so much feels uncertain.

What About Insurance, Bills, and Financial Help?

The financial dimension of a childhood cancer diagnosis can feel almost as overwhelming as the medical one. Treatment is expensive, and even families with good insurance often face significant out-of-pocket costs.

Here is what to know:

Financial stress is real, and it is valid. But help is available, and you do not have to figure it out alone. Your child’s treatment center should have a dedicated team to help you navigate every aspect of the financial side.

Finding Specialized Pediatric Cancer Care in Nevada

If you are a family in Nevada, Cure 4 The Kids Foundation is the state’s only dedicated pediatric cancer and rare disease treatment center, and we currently employ 100% of Nevada’s board-certified pediatric oncologists. Located at 1 Breakthrough Way in Las Vegas, our clinic provides comprehensive cancer care for children and adolescents, from diagnosis through treatment and into survivorship.

Cure 4 The Kids Foundation’s care model includes board-certified pediatric oncologists, a full multidisciplinary team, access to clinical trials, behavioral health support, genetic counseling, and dedicated family support services. Our foundation was established in 2007 with a simple but powerful promise: no child with cancer will be turned away because of an inability to pay.

You Are Not Alone in This

A childhood cancer diagnosis changes everything, but it does not mean you are navigating this alone. From the medical team caring for your child to the social workers helping your family to the other parents who understand exactly what you are going through, there is a community of support waiting for you.

Take it one day at a time. Ask every question you have. Accept every hand that reaches out. And know that the strength you need is not something you have to find on your own.

It is something that will be built, day by day, by the people standing beside you.

About the Author: Annette Logan-Parker brings over 30 years of experience in pediatric oncology to her role as Founder and Chief Advocacy & Innovation Officer at Cure 4 The Kids Foundation. She has dedicated her career to improving outcomes for children with cancer and ensuring equitable access to cutting-edge treatments for all families.

Frequently Asked Questions

The first and most important step is to make sure your child is connected with a board-certified pediatric oncologist at a specialized children’s cancer center. Pediatric cancers require treatment protocols designed specifically for children, and a pediatric specialist has the training and experience to guide your family through this process.

Ask your child’s pediatrician for a referral to a pediatric hematologist-oncologist. You can also search the American Society of Pediatric Hematology/Oncology (ASPHO) directory or contact a children’s hospital in your area. If you are in Nevada, Cure 4 The Kids Foundation is the state’s only dedicated pediatric cancer treatment center.

Many childhood cancers are highly treatable, and survival rates have improved significantly over recent decades. The prognosis depends on the type and stage of cancer, your child’s age and overall health, and the treatment plan. Your child’s pediatric oncologist can give you the most specific and accurate information for your child’s individual diagnosis.

Work with your child’s care team, especially child life specialists, to find age-appropriate language. Be honest, be reassuring, and let your child ask questions at their own pace. Children generally cope better when they have some understanding of what is happening, even if the details are simplified for their age.

Many resources exist, including hospital charity care programs, nonprofit organizations like the National Children’s Cancer Society and Alex’s Lemonade Stand Foundation, state Medicaid programs, and federal protections like FMLA for work leave. Your hospital’s social worker or financial counselor is the best first point of contact for identifying programs available to your family.

The Golden Hour: What Happens When Your Child Spikes a Fever During Cancer Treatment

Posted on by Jennifer Glover

Key Takeaways:

  • The Golden Hour is the critical 60-minute window to deliver antibiotics when a child with cancer spikes a fever.
  • Children with central lines (the tubes that deliver chemotherapy) are at high risk for serious infection because their immune systems are weakened.
  • Cure 4 The Kids Foundation reduced its average time to antibiotics from 85 minutes to 33 minutes, exceeding national benchmarks.
  • These results match or exceed outcomes from major academic children’s hospitals, achieved in an outpatient setting.
  • The improvement came from frontline staff examining every step of the process and finding ways to move faster—no expensive technology required.

When your child spikes a fever during cancer treatment, time slows down and speeds up all at once. You’re watching the clock. You’re watching your child. You’re watching the team move around you and wondering if everything is happening fast enough.

I’ve talked to enough parents to know that feeling. It stays with them.

I want to tell you what our team has been doing to honor that urgency.

What Is the Golden Hour in Pediatric Oncology?

The Golden Hour refers to the critical 60-minute window to deliver antibiotics to a child with cancer who develops a fever. Because chemotherapy weakens the immune system, children with central lines—the tubes that deliver treatment directly into their bloodstream—are at high risk for serious infection. Their immune systems can’t fight infection the way ours can, and that’s why getting antibiotics started within 60 minutes can be lifesaving.

What is Febrile Neutropenia?

You may hear your care team use the term “febrile neutropenia.” This simply means fever in a child whose immune system has been weakened by chemotherapy. “Febrile” means fever, and “neutropenia” means the body has very few neutrophils, which are the white blood cells that fight infection. So, because your child’s body can’t fight infection on its own, febrile neutropenia is treated as a medical emergency.

Where We Started

I believe in being honest with our families, and with ourselves. So here’s where we were a year ago: our average time was 85 minutes.

To put that in perspective, nationally, roughly half of pediatric emergency departments consistently meet the 60-minute goal. Major academic children’s hospitals—institutions with 24-hour pharmacies, dedicated emergency departments, and teams of residents—report median times between 55 and 75 minutes. Some published studies show baselines over 90 minutes prior to launching improvement initiatives.

We weren’t behind. By national standards, we were in the middle of the pack.

But “middle of the pack” isn’t good enough when it’s your child with a fever. Our team knew we could do better.

Why Outpatient Specialty Centers Can Move Faster

Here’s something important to understand: hospitals and outpatient centers are built for different things.

Hospitals are designed to handle everything—trauma, surgery, complex inpatients, emergencies of every kind. That breadth is their strength. But it also means a child with a fever may be one of dozens of urgent situations competing for attention at any given moment.

An outpatient specialty center like Cure 4 The Kids Foundation is different. We do one thing: care for children with cancer and rare diseases. When a child with a central line spikes a fever, they’re not waiting behind a car accident or a cardiac event. Our team knows them. Their chart is already open. The pharmacist who will compound their antibiotic is thirty feet away, not in a central pharmacy serving an entire hospital.

Neither model is better. They serve different purposes. But for this specific situation—a known patient, a predictable emergency, a race against the clock—the focused outpatient model has real advantages. And our team has learned to use every one of them.

Kids receiving infusions at Cure 4 The Kids Foundation

How Our Team Cut Time to Antibiotics in Half

This is the part that makes me proud.

A group of nurses, providers, pharmacists, and lab staff came together—not because anyone made them, but because they saw a problem and wanted to fix it. They walked through every step of the process. They asked hard questions. They challenged the way things had always been done.

They found minutes hiding everywhere. In the compounding suite. In the order sets. In the handoffs between teams. In the small hesitations that happen when people aren’t sure if they should ask for help.

And then they fixed them. One by one.

There was no magic solution. No expensive new technology. Just people who cared enough to look honestly at their work and commit to doing it better.

Where We Are Now: Cure 4 The Kids Foundation’s Golden Hour Results

Throughout 2025, we tracked every antibiotic administered to a patient with a central line.

Cure 4 The Kids Foundation’s Time to Antibiotics (2025)

Starting Baseline
85 minutes
2025 Average
57 minutes
December 2025
33 minutes
National Benchmark
60 minutes
National Pediatric ED Range
55–90+ minutes

We now consistently meet the Golden Hour benchmark. Some months, we’re well under it.

For context: These results put us on par with the best published outcomes from major academic children’s hospitals around the country—and we’re doing it as an outpatient clinic, without a 24-hour pharmacy, without a dedicated emergency department, without the infrastructure those institutions have.

Why I’m Sharing This

I’m not sharing this to brag. I’m sharing it because families deserve to know.

When I started Cure 4 The Kids Foundation in 2007, it was because I believed Nevada families shouldn’t have to leave home to get excellent care for their children. I’d seen too many families torn apart by distance—siblings separated, parents missing work, support systems left behind—because the assumption was that “real” pediatric cancer care happened somewhere else.

I wanted to build something that proved that wrong. This—what our team did in 2025—is that proof. Not because I told them to. Because it’s who they are.

To Our Families

If your child is being treated at C4K, here’s what I want you to know:

When your child spikes a fever, we feel the urgency too. We’re not just going through the motions. We’ve built systems to move fast, and we hold ourselves accountable to using them. We track our own performance—not because someone makes us, but because your child deserves that kind of attention.

You trusted us with the most precious thing in your life. This team takes that seriously. Every day. Every patient. Every minute.

Click Here to Explore Patient and Caretaker Resources

To the Cure 4 The Kids Foundation Team

I’ve watched this organization grow from a kitchen table idea to what it is today. I’ve seen a lot of things I’m proud of.

This is near the top.

Not because of the numbers—though they’re remarkable. Because of what the numbers represent: a team that looked at itself honestly, identified where it could do better, and then actually did it. Without excuses. Without waiting to be told.

That’s the C4K Way. And you lived it.

When I started C4K, people told me Nevada couldn’t support this kind of care. That families would always have to leave.

This team just proved them wrong, 33 minutes at a time.

This is why I built C4K. This right here is the whole point.

About the Author: Annette Logan-Parker brings over 30 years of experience in pediatric oncology to her role as Founder and Chief Advocacy & Innovation Officer at Cure 4 The Kids Foundation. She has dedicated her career to improving outcomes for children with cancer and ensuring equitable access to cutting-edge treatments for all families.

Why Pediatric Cancer Requires Specialized Care

Posted on by Jennifer Glover

Key Takeaways:

  • Children are not small adults. Pediatric cancers differ biologically from adult cancers and require treatment protocols designed specifically for growing bodies.
  • Specialized centers have better outcomes. Children with cancer treated at specialized, pediatric cancer centers where care is standardized and multidisciplinary have better survival outcomes than those treated in lower-volume or non specialty settings.
  • Growing bodies need growing expertise. Treatment must account for developing organs, bones, and brains—protecting your child’s future health while fighting cancer today.
  • Pediatric oncology teams are uniquely trained. From oncologists to nurses to child life specialists, every team member understands the specific needs of children with cancer.
  • The right center offers more than medicine. Comprehensive pediatric programs provide family support, educational continuity, and age-appropriate emotional care throughout treatment.

When your child is diagnosed with cancer, you want answers—and you want them now. One of the most important decisions you’ll face is where your child will receive treatment. Here’s what every parent needs to know about why specialized pediatric cancer care matters.

Why Can’t My Child Be Treated at a Regular Hospital?

This is one of the first questions many parents ask after their child’s diagnosis. It’s a fair question, especially when a well-respected hospital is close to home.

The short answer: Your child can receive care at many hospitals, but the quality of that care varies dramatically. Pediatric cancer is rare, highly specialized, and fundamentally different from adult cancer. Treatment requires expertise that most general hospitals simply don’t have.

Here’s why that matters for your child.

Children’s Bodies Are Different—And So Are Their Cancers

Childhood cancer isn’t the same disease as adult cancer. The types of cancer children develop, where they originate, and how they behave are biologically distinct.

Different Cancer Types 

The most common childhood cancers—leukemias, brain tumors, neuroblastoma, Wilms tumor, and lymphomas—are rarely seen in adults. Meanwhile, the cancers most common in adults (breast, lung, colon, prostate) almost never occur in children.

Different Biology 

Pediatric tumors often grow faster than adult cancers, but they also frequently respond better to treatment. This means protocols must be precisely calibrated—aggressive enough to work, but carefully designed to minimize long-term damage.

Different Causes

While many adult cancers are linked to lifestyle factors or environmental exposures over time, most childhood cancers arise from genetic changes during normal development. This means prevention strategies that work for adults don’t apply to children, and treatment approaches must account for these genetic differences.

Growing Bodies Need Specialized Treatment Protocols

Perhaps the most critical reason for specialized care is what’s happening inside your child’s body right now: growth.

Children’s organs, bones, brains, and hormonal systems are still developing. Cancer treatment—including chemotherapy, radiation, and surgery—can affect that development in ways that don’t apply to fully-grown adults.

Brain Development 

A child’s brain continues developing into their mid-twenties. Radiation and certain chemotherapies can impact cognitive development, memory, and learning. Pediatric specialists know which treatments carry these risks and how to modify protocols to best protect neurological function.

Bone Growth

Treatment can affect growth plates, potentially impacting height and skeletal development. Pediatric teams monitor growth carefully and adjust approaches when possible.

Fertility Preservation 

Some treatments affect future fertility. Pediatric specialists discuss preservation options before treatment begins—conversations that require specialized knowledge about age-appropriate options.

Heart and Organ Health 

Certain chemotherapy drugs can affect heart function differently in children than adults. Pediatric protocols include specific monitoring and dosing adjustments to protect developing organs.

Adult oncologists—even excellent ones—aren’t often trained to navigate these developmental considerations. Pediatric oncologists spend their entire careers understanding how to balance effective treatment with protecting a child’s future.

The Cure 4 The Kids Foundation Building at 1 Breakthrough Way in Las Vegas, Nevada
Cure 4 The Kids Foundation at 1 Breakthrough Way, Las Vegas, NV 89135

Specialized Centers Have Access to Pediatric-Specific Clinical Trials

When standard treatments aren’t enough, clinical trials offer hope. But pediatric clinical trials are different from adult trials—and they’re only available at certain centers.

Why this matters: In the United States, at least half—and in many series more than 60%—of children with cancer are treated on clinical trials, compared to a small minority of adults (generally less than 5%). 

High participation in pediatric-specific clinical trials, often coordinated through national cooperative groups, has been a key driver of the dramatic increase in childhood cancer survival from around 60% in 1970 to over 85% today.

Pediatric cancer programs participating in research give families access to the latest treatment advances. General hospitals typically don’t participate in these networks, often because they lack a dedicated pediatric oncology program.

What Makes a Pediatric Cancer Team Different?

Specialized pediatric cancer care isn’t just about having a doctor who treats children. It’s about an entire team trained to care for young patients and their families.

  • Pediatric oncologists and hematologists: Physicians who completed fellowships specifically in childhood cancer, with ongoing training in the latest pediatric protocols.
  • Pediatric oncology nurses: Nurses certified in administering chemotherapy to children, managing pediatric ports and central lines, and recognizing symptoms specific to young patients.
  • Child life specialists: Professionals trained to help children understand and cope with their diagnosis and treatment through play, preparation, and emotional support.
  • Pediatric psychologists and social workers: Mental health professionals who specialize in helping children and families navigate the emotional impact of cancer.
  • Pediatric pharmacists: Pharmacists who understand pediatric dosing—which is calculated differently than adult dosing and requires specialized expertise to ensure safety and effectiveness.
  • Educational liaisons: Staff who coordinate with your child’s school to maintain educational continuity during treatment.

This multidisciplinary approach is essential for comprehensive care.

What to Look for in a Pediatric Cancer Program

Not all pediatric programs are equal. When evaluating where your child will receive care, consider these factors:

  • Board-certified pediatric oncologists and hematologists. Confirm that physicians are specifically trained and certified in pediatric oncology—not adult oncologists who “also see children.”
  • Multidisciplinary care team. Look for programs with dedicated pediatric oncology nurses, child life specialists, social workers, and mental health support integrated into the care team.
  • Clinical trial access. Ask whether the program participates in the Children’s Oncology Group (COG) or other pediatric research consortiums. Access to clinical trials can be lifesaving.
  • Survivorship programs. Long-term follow-up care is essential. Ask about dedicated survivorship clinics that monitor for late effects of treatment into adulthood.
  • Family-centered support services. Comprehensive programs offer family support including financial counseling, sibling support, educational coordination, and caregiver resources.
  • Experience with your child’s specific diagnosis. Pediatric cancers are rare, and some are extremely rare. Ask how many children with your child’s diagnosis the center treats annually.

The Survival Rate Difference

The progress in childhood cancer survival is one of medicine’s greatest success stories. Today, more than 80% of children with cancer in countries like the US survive at least five years, compared with less than 25% in the 1960s.

But this progress happened because of specialized pediatric research and treatment—not in spite of it. The dramatic improvements came from pediatric-specific clinical trials, protocols designed for children’s bodies, and care delivered by teams dedicated exclusively to young patients.

When families choose specialized pediatric cancer care, they’re giving their child access to the expertise that created these survival rates.

Your Child Deserves Specialized Care

As a parent, you’re your child’s most important advocate. Understanding why specialized care matters is the first step in ensuring your child receives the best possible treatment.

Pediatric cancer is rare, and it requires rare expertise. The physicians, nurses, and support staff at dedicated pediatric cancer programs have devoted their careers to one mission: helping children survive cancer and thrive afterward.

Your child is not a small adult. They deserve care designed for exactly who they are: a child with their whole life ahead of them.

About the Author: Annette Logan-Parker brings over 30 years of experience in pediatric oncology to her role as Founder and Chief Advocacy & Innovation Officer at Cure 4 The Kids Foundation. She has dedicated her career to improving outcomes for children with cancer and ensuring equitable access to cutting-edge treatments for all families.

Why the UN’s Childhood Cancer Recognition Matters for Nevada Families

Posted on by Jennifer Glover

Key Takeaways:

  • The United Nations is poised to formally recognize childhood cancer in its Fourth High-Level Meeting on Non-Communicable Diseases—a historic first that could reshape global and local healthcare priorities.
  • Because the draft declaration did not pass by consensus in September 2025, it must go to a formal vote of the full UN General Assembly, where the childhood cancer language remains vulnerable to removal.
  • For Nevada—a state with significant pediatric subspecialty shortages—global recognition would strengthen funding pathways, research partnerships, and legislative momentum for childhood cancer and rare disease care.
  • Cure 4 The Kids Foundation, as a member of Childhood Cancer International (CCI), is calling on Nevada’s healthcare community, policymakers, and advocates to support retaining childhood cancer in the final declaration.

Every week at Cure 4 The Kids Foundation, a child sits across from us whose entire future depends on timely diagnosis, coordinated care, and a system strong enough to support their family through the fight of their lives. These aren’t hypothetical scenarios or distant policy discussions—they’re the reality for Nevada families navigating childhood cancer right now.

That’s why what’s happening at the United Nations matters deeply, not just in theory, but in the most practical, immediate, life-changing ways.

For the first time in history, the draft Outcome Declaration for the UN’s Fourth High-Level Meeting on Non-Communicable Diseases (NCDs) includes childhood cancer. This represents a breakthrough moment in global health policy—one that has the potential to reshape how nations prioritize, fund, and coordinate pediatric cancer care.

And it is fragile.

Understanding the Stakes: What’s Happening at the UN

The UN’s High-Level Meetings on NCDs occur approximately every 4–7 years and set the global agenda for how countries address diseases like cancer, diabetes, and cardiovascular conditions. Historically, these declarations have focused almost exclusively on adult populations, leaving childhood cancer—and the unique needs of pediatric patients—largely invisible in global health policy.

The current draft declaration changes that. For the first time, childhood cancer is explicitly named, acknowledging that children face distinct challenges that require dedicated attention, resources, and systems of care.

However, because the declaration did not achieve consensus approval during the September 2025 session, it must now proceed to a formal vote before the full UN General Assembly. Until that vote occurs—which could be scheduled at any time—the childhood cancer language remains vulnerable. 

It can still be amended, weakened, or removed entirely.

Globally, childhood cancer is diagnosed in approximately 400,000 children each year. In the United States, cancer remains the leading cause of death by disease after infancy among children. Yet despite this, pediatric oncology has historically received a fraction of the research funding and policy attention given to adult cancers.

The Cure 4 The Kids Foundation Building at 1 Breakthrough Way in Las Vegas, Nevada

Why Nevada Cannot Afford to Lose This Moment

Nevada faces unique challenges in pediatric healthcare that make global recognition of childhood cancer particularly consequential for our state.

We have one of the lowest ratios of pediatric subspecialists per capita in the nation. In fact, according to a sobering KNPR report, “depending on where you look, the state ranks between 46th and 49th in number of pediatric doctors per capita.” Families in rural Nevada often travel hundreds of miles (including across state lines) to access specialized care, and our state has historically ranked among the lowest for children’s healthcare access and outcomes.

These aren’t failures of will—they’re structural gaps that require sustained policy attention, dedicated funding streams, and workforce development initiatives to address. Global recognition of childhood cancer as a priority area for NCDs would provide critical support for the work Nevada has already begun.

How the UN Declaration Aligns With Nevada’s Strategic Healthcare Priorities

At Cure 4 The Kids Foundation, our strategic plan—Here We Grow Again—is built around five pillars: Disruption, Radical Relationships, Innovation, Workforce Development, and Equity in Access. The inclusion of childhood cancer in the UN declaration strengthens each one.

Disruption: Building What Children Truly Need

Childhood cancer has been overlooked globally for decades because healthcare systems were structured around adult needs. The assumption that pediatric care could simply be scaled-down adult care has proven inadequate—children’s bodies, developmental stages, and long-term survivorship needs are fundamentally different.

Experts and advocates in Nevada have long rejected that model. Recognition at the UN level validates what we’ve known: children are not small adults, and their care cannot be an afterthought. This global acknowledgment creates leverage for continued investment in pediatric-specific infrastructure, protocols, and training.

Radical Relationships: Collaboration Across Borders

Strategic growth in pediatric healthcare requires bold partnerships—with universities, policymakers, health systems, and global organizations. As proud members of Childhood Cancer International (CCI), Cure 4 The Kids Foundation stands with advocates worldwide who are working to protect the childhood cancer language in this declaration.

CCI is a global network of member organizations, allies, and collaborative partners that has been instrumental in elevating childhood cancer on the global stage. Nevada’s participation in this international movement positions our state’s healthcare institutions for expanded collaboration, knowledge sharing, and partnership opportunities.

Innovation: Strengthening the Systems Behind the Care

Nevada has made significant investments in healthcare infrastructure that directly supports children with cancer and rare diseases. We’re building registries, we’re modernizing genetics infrastructure through expanded newborn screening, and developing psychosocial and behavioral health pathways that recognize the whole-family impact of pediatric illness.

Global recognition fuels these initiatives by opening doors for new research opportunities, improving data integration across systems, and attracting workforce talent to Nevada. When childhood cancer is recognized as a global priority, the funding and partnership landscape shifts accordingly.

Workforce Development: Addressing Nevada’s Most Critical Barrier

The UN declaration specifically highlights the need for a pediatric-focused NCD workforce—precisely what Nevada is fighting to build.

Through initiatives like SB165—a bill designed to create a new licensed profession called the Behavioral Health and Wellness Practitioner that also establishes a regulatory framework for this practice—and academic partnerships, telehealth expansion, and the ongoing work of the Nevada Rare Disease Advisory Council (NV-RDAC), we are actively addressing these gaps. Global recognition adds momentum and legitimacy to these efforts, helping attract federal attention and resources to Nevada’s workforce challenges.

Equity in Access: Ensuring No Child Is Left Behind

Recognition on the world stage supports the priorities most central to improving outcomes: early diagnosis, coordinated care systems, and equitable access to high-quality pediatric treatment regardless of geography or socioeconomic status.

For Nevada families—particularly those in rural areas or underserved communities—this matters enormously. When childhood cancer is prioritized globally, it strengthens the case for investments in telehealth infrastructure, transportation support, family navigation services, and the other wraparound resources that determine whether a child can actually access the care they need.

What Nevada Stands to Gain…Or Lose

If childhood cancer remains in the final UN declaration, Nevada gains:

  • Stronger alignment with federal and global health priorities, positioning the state favorably for grants, demonstration projects, and policy initiatives. 
  • Increased eligibility for research funding and international partnerships that could bring new clinical trials and treatment options to Nevada families. 
  • Reinforcement for Nevada’s legislative progress, including the work of NV-RDAC and initiatives advancing through the state legislature. 
  • Momentum for the 2026–2028 NV-RDAC State Plan, which will guide Nevada’s approach to rare diseases and childhood cancer for years to come. 
  • Validation for Nevada’s investments in early detection, data systems, and workforce development—demonstrating that our state is aligned with international best practices.

If the childhood cancer language is removed, this rare global opportunity disappears. The policy momentum we’ve built over the last decade becomes harder to advance. Nevada’s efforts to attract pediatric specialists, secure federal funding, and build sustainable infrastructure lose a critical source of support.

This is structural—the kind of foundational shift that determines what’s possible for the next generation of Nevada children facing cancer.

Now Nevadans Must Use Our Voice

Nevada has spent the last decade building the foundation for better pediatric cancer care. Now, as the world considers whether to formally recognize childhood cancer as a global health priority, we have both an opportunity and a responsibility to stand with the international community.

As Founder of Cure 4 The Kids Foundation and Chair of NV-RDAC, I am urging our partners, policymakers, healthcare providers, and advocates across Nevada: 

This is the moment to pay attention. This is the moment to act.

Cure 4 The Kids Foundation proudly supports the global effort to retain childhood cancer in the final UN declaration. Because when the world recognizes children with cancer, it strengthens every system we are fighting to build—for Nevada, and for every child, everywhere.

About the Author: Annette Logan-Parker brings over 30 years of experience in pediatric oncology to her role as Founder and Chief Advocacy & Innovation Officer at Cure 4 The Kids Foundation. She has dedicated her career to improving outcomes for children with cancer and ensuring equitable access to cutting-edge treatments for all families.

How the AKAC and GKAC Acts Could Transform Pediatric Care

Posted on by Jennifer Glover

Key Takeaways:

  • What are the AKAC and GKAC Acts? Two bipartisan federal bills working to remove systemic barriers in pediatric cancer and rare disease care by streamlining Medicaid enrollment for out-of-state specialists (AKAC) and accelerating pediatric drug development (GKAC).
  • Why do the AKAC and GKAC Acts matter for children with cancer and rare diseases? The AKAC Act eliminates administrative delays that prevent families from accessing specialized care across state lines, while the GKAC Act ensures children gain earlier access to innovative cancer therapies already being studied in adults.
  • How would the AKAC Act improve access to pediatric specialists? By creating a simplified enrollment pathway for qualified out-of-state providers already in good standing with Medicare or another state’s Medicaid program, reducing weeks of bureaucratic delays that can compromise treatment outcomes.
  • What changes would the GKAC Act bring to pediatric cancer research? It expands FDA authority to require earlier pediatric studies of promising combination therapies and extends the Rare Pediatric Disease Priority Review Voucher Program through 2029, incentivizing pharmaceutical companies to invest in treatments for children.
  • How do access and innovation work together in pediatric care? Improving provider access through AKAC means nothing without better treatments available through GKAC, while innovative therapies developed through GKAC research only help children who can actually reach qualified specialists supported by AKAC reforms.

When a family learns their child has cancer or a rare disease requiring specialized treatment unavailable locally, they face an immediate crisis. Within days, they must coordinate care with distant specialists, navigate insurance approvals, and often travel across state lines while their child’s condition progresses. At Cure 4 The Kids Foundation, we know that barriers to care aren’t always medical. Sometimes, they’re bureaucratic. And in pediatric oncology and rare disease treatment, bureaucratic delays can have devastating consequences.

The Hidden Barriers to Kids’ Healthcare Most Families Face

Two systemic issues create unnecessary obstacles for families seeking specialized pediatric care. Administrative barriers force families to wait weeks for out-of-state Medicaid provider enrollment while their child’s treatment window closes. Research lag excludes children from early-stage drug studies, meaning therapies that could save lives remain unavailable to pediatric patients for years after demonstrating promise in adults.

These issues translate directly into delayed care and fewer treatment options for kids. When a child needs a bone marrow transplant specialist in another state, Medicaid enrollment requirements can add weeks to an already compressed timeline. When a promising combination therapy shows remarkable results in adult cancer patients, children with the same disease type often wait years before that treatment becomes available in pediatric formulations or dosing protocols. 

In pediatric cancer, the difference between timely care and delayed care is measured in weeks—and weeks are a luxury children do not have.

What Is the Accelerating Kids’ Access to Care Act (AKAC)?

The Accelerating Kids’ Access to Care Act addresses the administrative maze families encounter when seeking out-of-state specialized care. This bipartisan legislation creates an opt-in enrollment pathway for qualified providers already in good standing with Medicare or another state’s Medicaid program, allowing them to participate in multiple state programs without duplicating the entire credentialing process.

The AKAC Act specifically targets children with complex or rare conditions who often need to cross state lines to reach specialists with the expertise their cases require. Families in Nevada frequently travel to California, Arizona, Utah, or even farther for advanced procedures like bone marrow transplant, rare disease treatment protocols, or clinical trials. In these cases, the medical urgency is clear, but the administrative pathway is slow. Under current systems, even when a family identifies the right specialist and secures a referral, Medicaid enrollment requirements in the provider’s state can delay treatment for weeks.

How Does AKAC Remove Red Tape?

What makes AKAC particularly effective is that it reduces administrative duplication while keeping state authority over authorizations and payment rates intact. States maintain control over which providers can participate and how services are reimbursed. The legislation simply removes the redundant paperwork that forces qualified providers to complete separate, lengthy enrollment processes for each state’s Medicaid program.

We’ve seen firsthand how weeks of waiting for a provider to be enrolled can mean the difference between timely treatment and avoidable complications. In pediatric cancer and rare disease care, treatment timing directly affects outcomes. A delay measured in weeks can allow disease progression that makes subsequent treatment less effective or even impossible. The AKAC Act recognizes that children with serious illnesses cannot afford to wait while administrators process paperwork for providers who are already qualified and practicing successfully in neighboring states.

How the Give Kids a Chance Act (GKAC) Brings Innovation to Children Faster

The Give Kids a Chance Act tackles a different but equally critical barrier. Children with cancer shouldn’t have to wait years for access to innovative therapies that are already improving survival rates in adults. Current drug development pathways often study combination therapies in adult populations first, then conduct separate pediatric trials years later if companies choose to pursue pediatric indications. This sequential approach means children miss out on potentially life-saving innovations during their most critical treatment windows.

The GKAC Act expands FDA authority to mandate pediatric studies when adult data already shows promise, particularly for combination therapies. Many of the most effective cancer treatments today involve combining multiple drugs to target disease through different mechanisms. When these combinations demonstrate significant benefits in adult trials, the GKAC Act ensures that pharmaceutical companies must also study appropriate pediatric applications rather than treating pediatric development as optional.

How Does GKAC Incentivize Pharmaceutical Companies?

GKAC not only accelerates pediatric studies, it also strengthens the Rare Pediatric Disease Priority Review Voucher Program through 2029. This program incentivizes companies to invest in therapies for children with rare diseases by providing vouchers that can expedite FDA review of other drugs in their pipeline. By extending and strengthening this program, the GKAC Act makes pediatric rare disease drug development more financially viable for pharmaceutical companies, addressing the market dynamics that historically under-invest in pediatric populations.

This bill aligns perfectly with our mission to bring the most advanced, research-based treatments to Nevada families. At Cure 4 The Kids Foundation, we’ve built our clinical programs around the principle that children deserve access to cutting-edge therapies informed by the latest research. The GKAC Act helps bridge the gap between adult cancer research breakthroughs and their availability to pediatric patients, ensuring that promising innovations reach children during their treatment journey rather than years after they first needed them.

Why Federal Progress Matters for Nevada Families

The AKAC and GKAC Acts complement each other in ways that directly address challenges Nevada families face. One removes red tape that delays treatment. The other accelerates research so that better treatments reach children sooner. Together, they create a system where families can access the right specialists without bureaucratic delays and those specialists have innovative, evidence-based treatment options available.

This federal progress connects directly to our local advocacy work at Cure 4 The Kids Foundation. As we work to establish Nevada’s first in-state Pediatric Stem Cell and Bone Marrow Transplant Program, we’re addressing the same fundamental issue the AKAC Act targets—eliminating unnecessary barriers between children and specialized care. When Nevada children no longer need to travel out of state for bone marrow transplants, their families avoid the Medicaid enrollment challenges AKAC addresses. But until that program launches, AKAC will make out-of-state referrals significantly faster and less burdensome.

Similarly, as we advance outpatient treatment models and expand our clinical trial portfolio, the GKAC Act ensures that the innovative therapies we bring to Nevada reflect the latest research developments. Federal and state action work together to make comprehensive, equitable care possible. National legislation creates frameworks that support local program development, while local programs like ours demonstrate the real-world impact of improved access and innovation.

Understanding How Access and Innovation Connect

It’s tempting to view access and innovation as separate policy goals, but in pediatric specialty care, they’re inseparable. The most innovative cancer therapy provides no benefit to a child who cannot reach a qualified oncologist trained to administer it. Conversely, excellent access to specialists means little if those specialists lack effective treatment options.

The AKAC and GKAC Acts recognize this interconnection. By addressing both administrative access barriers and research development timelines, these bills create conditions where children can benefit from medical advances in real time rather than years after those advances occur. 

When you’re navigating treatment for a child with a serious illness, you don’t distinguish between “access problems” and “innovation problems.” You simply want your child to see the right doctor and receive the best available treatment as soon as possible. The AKAC and GKAC Acts work together to make that straightforward goal much more achievable.

What Families and Supporters Can Do

While these bills work their way through Congress, families and advocates can take several steps to support their passage and prepare for the improvements they’ll bring. Learning more about both pieces of legislation helps build public understanding of why these specific policy changes matter. Organizations like the Coalition Against Childhood Cancer (CAC2), Children’s Cancer Cause, and the EveryLife Foundation provide resources and advocacy opportunities for those interested in supporting these federal efforts.

Sharing this message with your networks—whether through social media, conversations with local elected officials, or discussions within patient advocacy groups—helps build momentum for bipartisan healthcare improvements that directly benefit children. These bills have attracted support from both sides of the aisle because they address clear, documented problems with practical solutions.

At Cure 4 The Kids Foundation, we’ll continue working alongside Nevada families and national partners to make sure no child waits for the care or innovation they deserve. Our advocacy extends from our clinic in Las Vegas to state legislative efforts and national policy conversations, because improving outcomes for children with cancer and rare diseases requires action at every level.

Kids Can’t Wait

The timeline of childhood cancer and rare disease doesn’t align with administrative convenience or traditional drug development schedules. 

The Accelerating Kids’ Access to Care Act and the Give Kids a Chance Act recognize this fundamental truth. Kids can’t wait—not for enrollment forms, not for research pipelines, not for tomorrow’s treatments. These bills represent meaningful steps toward a healthcare system that matches the urgency of pediatric illness with the speed of access and innovation children deserve.

As these pieces of legislation move forward, they carry the hopes of every family who has faced bureaucratic delays while seeking specialized care and every family who has watched their child’s treatment options limited by slow pediatric drug development. By breaking down barriers to both access and innovation, the AKAC and GKAC Acts move us closer to a system where every child can reach the right specialist and receive the most advanced care available, regardless of where they live or which state lines they need to cross for treatment.

About the Author: Annette Logan-Parker brings over 30 years of experience in pediatric oncology to her role as Founder and Chief Advocacy & Innovation Officer at Cure 4 The Kids Foundation. She has dedicated her career to improving outcomes for children with cancer and ensuring equitable access to cutting-edge treatments for all families.

When Research Funding Shrinks, Nevada’s Most Vulnerable Patients Pay the Price

Posted on by Jennifer Glover

Key Takeaways:

  • Nevada receives among the lowest NIH funding in the nation—ahead of only Alaska and Wyoming—making our research ecosystem especially vulnerable to federal cuts.
  • Philanthropy cannot replace federal investment. Private foundations account for just 1.2% of medical research spending in the U.S., while the federal government accounts for 25%. Even extraordinary philanthropic efforts cannot backfill meaningful federal reductions.
  • The consequences cascade quickly: Young researchers leave the state, clinical trials close, patients lose access to cutting-edge treatments, and families return to the old Nevada reality of “pain, get on a plane.”
  • Nevada has made enormous progress—achieving R1 research status at both major universities, establishing the Nevada Rare Disease Advisory Council, and building partnerships that bring clinical trials home. But this ecosystem remains fragile.
  • Research funding determines whether Nevada continues advancing care or falls backward. For children with cancer, rare disease patients, and Nevada’s rapidly growing senior population, these aren’t budget numbers—they’re timelines for hope.

Clinical Studies
Research saves lives—plain and simple.
 
Every breakthrough that transformed modern medicine was sparked by research fueled largely by federal investment through the National Institutes of Health (NIH). From immunotherapy for cancer to the diagnostics that extend life for children with rare diseases, none of it would exist without the decades-long commitment of public research dollars.
But today, that lifeline is under threat.
 
Recent federal proposals to cut NIH funding—and delays in distributing existing grant dollars—are creating real fear among researchers, clinicians, and families across the country. Here in Nevada, where research infrastructure is still young and fragile, the impact could be far more severe.
 
And let me be clear: Nevada cannot afford to lose ground. Our patients cannot afford for progress to slow—even by a single year.

Nevada Depends on Research More Than Most States

Nevada receives among the lowest NIH funding in the nation—ahead of only Alaska and Wyoming. That’s not because our needs are lower; it’s because our research ecosystem is still developing.
 
We’ve made enormous strides:
 
  • UNR and UNLV both achieved the prestigious R1 “Very High Research Activity” classification.
  • State investments in research infrastructure have grown.
  • Nonprofits—including Cure 4 The Kids Foundation and the Lou Ruvo Center—have brought clinical trials and emerging science home to Nevada families.

But this ecosystem is still delicate, and when federal funding becomes uncertain, the consequences cascade quickly:

  • Young researchers leave the state or the field entirely.
  • Labs lose momentum because science can’t be turned on and off.
  • Patients lose access to cutting-edge treatments and clinical trials close to home.
  • Families are forced back into the old Nevada reality: “pain, get on a plane.”
For rare disease and pediatric cancer patients—who already face delayed diagnoses, limited specialists, and complex treatment pathways—these setbacks can cost not just years, but lives.

Philanthropy Can Spark Progress—But It Cannot Replace Federal Investment

Nevada is incredibly generous. From the Keep Memory Alive Rodeo to 5K fundraisers and galas statewide, philanthropy is part of the fabric of our community.
 
These efforts matter. They help researchers test ideas, build proof-of-concepts, and create momentum that leads to larger federal grants.
 
But philanthropy represents just 1.2% of medical research spending in the U.S. Industry accounts for 66%. The federal government accounts for another 25%.
 
This means even the most extraordinary philanthropic efforts simply cannot backfill a meaningful federal reduction. As one national expert said: “There’s no way foundations can fill the gap.”

Federal Cuts Have Real Human Consequences

Nevada researchers are already feeling the fallout of uncertainty. One UNR research associate had to leave her NIH-funded lab position when delays in grant disbursement caused the funding to lapse. She moved to a different field—one less connected to patient care and scientific advancement.
 
This is not an isolated story. Delays pull graduate students, early-career researchers, and skilled lab staff away from critical work. Some never return. Every time this happens, we lose knowledge, momentum, and years of potential discovery.
 

This brain drain is devasting for Nevada, a state battling:

  • Some of the fastest-growing Alzheimer’s rates
  • The nation’s lowest childhood cancer research participation
  • A severe shortage of pediatric specialists, and
  • One of the most underserved rare disease populations

Why It Matters for Children With Cancer and Rare Diseases

At Cure 4 The Kids Foundation, we see firsthand the power of research. NIH-supported studies have created therapies that now cure over 80 percent of childhood cancers and have begun opening pathways for rare genetic diagnoses that once had no hope.
 
Our partnership in national research networks—COG, NANT, and disease-specific collaborations—brings the most advanced science directly to Nevada families. The state’s Rare Disease Advisory Council (NVRDAC) is using data from our Nevada Rare Disease Needs Assessment and the Nevada Cancer & Rare Disease Registry to shape smarter policy built on real patient experiences.
 

None of this happens if research stalls.

  • Families lose access to clinical trials.
  • Promising treatments slow down.
  • Early-phase discoveries never reach the bedside.

Nevada’s Strength Is Its Willingness to Build—Now We Must Protect What We’ve Built

Nevada has never been afraid to take bold steps:

  • We built a statewide pediatric oncology program from scratch.
  • We created a Rare Disease Advisory Council when most states had none.
  • We expanded newborn screening and modernized genetic care.
  • We established the Nevada Cancer & Rare Disease Registry—the first of its kind in the state.
  • We invested in research universities, upgraded infrastructure, and positioned Nevada to compete nationally.
But these achievements sit on a knife’s edge. NIH cuts aren’t just numbers in a budget line—they determine whether our state continues advancing care or falls backward.

Infusion/Ambulatory Center

A Call to Protect Research—and the Patients Behind It

Nevada’s future in scientific discovery depends on the stability, strength, and predictability of federal research funding.
 
As leaders in healthcare, government, and philanthropy, we must:
 
1. Advocate fiercely for protecting NIH funding. Research is a public good. It belongs to every family.
 
2. Maintain and expand Nevada’s state investments. State support has helped us climb into national competitiveness—we cannot retreat.
 
3. Strengthen public-private partnerships. Philanthropy should spark innovation, not rescue it.
 
4. Build sustainable research career pathways in Nevada. To retain scientists, we must create stable funding environments.
 
5. Ensure that rare disease and pediatric cancer patients remain at the center.
 
Their needs are urgent. Their timelines are short. Their voices must shape our priorities.
 

Hope Is Still on Our Side

Nevada has a long history of proving people wrong. We innovate quickly, we collaborate deeply, and we build infrastructure at a pace most states envy.
 
And our researchers—at C4K, Lou Ruvo, UNLV, UNR, and across the state—are rising to the challenge with creativity, resilience, and a fierce commitment to the communities they serve.
 
But they cannot do it alone.
 
We need stable, sustained research funding so that the next breakthrough happens here—and so Nevada families don’t have to leave their state or their support systems when facing the hardest moments of their lives.
 
Our children, our seniors, and our rare disease community are counting on us to stand up for science.
 
And we must.
 
Because in Nevada, research isn’t optional. It’s life-saving.

About the Author: Annette Logan-Parker brings over 30 years of experience in pediatric oncology to her role as Founder and Chief Advocacy & Innovation Officer at Cure 4 The Kids Foundation. She has dedicated her career to improving outcomes for children with cancer and ensuring equitable access to cutting-edge treatments for all families.

Reflections from Golf 4 The Kids 2025

Posted on by Jennifer Glover

Key Takeaways:

  • Participants ranged from patient families to caregivers to community organizations, embodying the spirit of Southern Nevada’s support for childhood cancer care
  • For the first time, Cure 4 The Kids is sharing founder Annette Logan-Parker’s signature Bloody Mary recipe, a tournament tradition since day one
  • The 2025 tournament brought together existing supporters and new partners in challenging philanthropic times, proving community strength
  • Volunteers and staff created personal connections with every golfer, reflecting C4K’s culture of care beyond the clinic
  • The tournament demonstrated Southern Nevada’s unwavering support for children battling cancer and rare diseases

Golfing to make an impact at Golf 4 the Kids 2025

Reflections from Golf 4 The Kids 2025

The sun was barely peeking over the fairways at Red Rock Country Club when I arrived at 6:00 AM on October 27th, arms loaded with Bloody Mary mix, vodka, and a handwritten note from Annette that simply read: “Keep the pour light, the mix cold, and the love heavy-handed.”

For the first time in the history of Golf 4 The Kids, I was taking over the signature Bloody Mary tent!

A Made-With-Love Morning Cocktail

If you’ve attended our Halloween Golf Tournament before, you know that Annette’s Bloody Mary tent isn’t just a refreshment stop—it’s where the day truly begins. Positioned right where golfers collect their carts, it’s become the heart of the tournament, a place where our founder personally greets every participant, thanks them for being there, and sends them off with something made with care.

The tradition started with the very first Golf 4 The Kids tournament. Back then, Annette was cooking breakfast burritos at staff meetings, arriving early to prepare meals in the clinic kitchen when our team was half its current size. Her hands-on approach to hospitality has always defined who we are as an organization. The Bloody Mary tent is an extension of that same spirit—a reminder that at Cure 4 The Kids Foundation, we put our whole hearts into everything we do.

A Day of Sunshine, Laughter, and Purpose

By the time our golfers started arriving, the course was alive with possibility. We had 21 incredible sponsors supporting the day, including 1Care Kids in their second year as presenting sponsor—a partnership we’re deeply grateful for. Nine new sponsors joined the C4K family this year, from caregivers and patient families to community organizations and heroes like the Clark County Firefighters: Local 1908. Several have already committed to making this an annual tradition.

The tournament itself was everything we’d hoped for: beautiful fall weather, activities at 16 of the 18 holes—everything from pirate-themed rum tastings to whiskey samplings and games—and volunteers who brought so much heart to the course. Many of our volunteers were C4K staff members who traded their clinic shifts for the day, and the feedback from golfers was overwhelming. They were genuinely moved by the passion and knowledge our team brought to every interaction.

The costume contest brought Halloween flair to the fairways, with our grand prize winner earning his title by golfing the entire tournament dressed as a piñata. Two lucky golfers earned shots at the $1 million and $100,000 prizes, and while neither made the 135-yard hole-in-one, everyone had fun and excitement was flying high!

But what made this year special wasn’t captured in any single moment. It was the laughter over Bloody Marys at sunrise. The parents of patients who participated, transforming their personal journeys into advocacy. The engaged conversations between Christine, our CEO, and community members who wanted to understand our mission more deeply. The way complete strangers became part of the C4K family on the golf course.

Our costume contest winner at Golf 4 the Kids 2025!

Annette’s Bloody Mary Recipe Revealed

For years, golfers have asked Annette for her Bloody Mary recipe. And for years, she’s smiled and kept it close. But traditions grow stronger when they’re shared, when they can be recreated in homes and gatherings beyond the golf course.

This year, with Annette off-site for the first time, she shared her closely-guarded recipe and trusted me to carry on the tradition. Even better, now she’s making the recipe public for the first time!

Download the recipe card and bring a little extra love from Cure 4 The Kids Foundation into your kitchen. Whether you’re hosting friends or planning your own fundraising event, this recipe carries the spirit of everything we do at C4K—made from scratch, made with care, and made for connection.

Note from Annette: This is a small-batch version of our event favorite! Rich, garden-fresh, and made with love.

CLICK HERE TO DOWNLOAD THE FULL RECIPE CARD!

Passing the Torch

Taking over the Bloody Mary tent this year meant more to me than mastering measurements and garnish placement. It represented something central to C4K’s culture: the deliberate passing of traditions, the mentoring of new leaders, and the assurance of continuity in everything we do.

That same principle guides us in the clinic every day. When Christine Tonn stepped into the CEO role, bringing her extensive background in nonprofit healthcare finance and her commitment to continuous improvement, she ensured that C4K’s mission would continue to thrive. Strong leadership is at its best when it preserves the heart of an organization while building capacity for the future.

At Cure 4 The Kids Foundation, we always invest in the next generation. We document. We train. We pass along not just the “what” but the “why” because traditions matter. Culture matters. And the kids we serve deserve an organization full of heart that’s built to last.

Here’s to Next Year!

As the event wrapped up, I thought about all the golfers who’d stopped by that morning. Some were longtime supporters who hugged me and said, “Annette would be proud.” Others were first-time participants who told me they’d be back next year, and the year after that.

The funds raised at Golf 4 The Kids are vital to advancing cures and treatment for kids with cancer and rare diseases, and on behalf of Cure 4 The Kids Foundation, I want to extend my thanks and gratitude. It’s so beautiful to see the community that forms when people gather around a shared purpose.

Thank you to every golfer, sponsor, and volunteer who made this year’s tournament unforgettable. Thank you to the Cure 4 The Kids team for getting the word out and securing so many wonderful sponsors. Thank you for showing up and for caring deeply about Nevada’s children who are fighting the toughest battles of their lives.

And thank you, Annette, for trusting me (and all of us!) with your recipe!

Here’s to good friends, great golf, and lasting traditions! Cheers to another amazing year, and to many more to come.

Amber Williams, Director of Communications at Cure 4 The Kids Foundation

About the Author: Amber Williams serves as Director of Communications at Cure 4 The Kids Foundation, where she has spent over 8 years building connections between the organization and the Southern Nevada community. She is passionate about ensuring every family knows they have a place to turn when their child needs specialized care.

Why Do Kids Get Cancer?

Posted on by Jennifer Glover

Key Takeaways:

  • Childhood cancer typically results from random genetic mutations that occur during rapid cell growth and development, not from lifestyle or environmental factors.
  • Most childhood cancers cannot be prevented, and they’re not caused by anything parents did or didn’t do.
  • Genetic changes in childhood cancer are usually acquired, not inherited—less than 10% of childhood cancers are linked to inherited genetic mutations.
  • Children’s cancers differ fundamentally from adult cancers, as they develop in different cell types and respond differently to treatment.
  • Research is advancing our understanding of childhood cancer causes, leading to better treatments and improved survival rates.

Pediatric Palliative Care
Dr. Waseem Alhushki, Director of Oncology & Long-Term Follow-Up Clinic at Cure 4 The Kids Foundation

When a child is diagnosed with cancer, one of the first questions families ask is “Why?” It’s a natural response to a devastating diagnosis. Understanding why children get cancer can help families process this difficult reality. 

Here’s the most straightforward answer: Most childhood cancers develop because of random, unpredictable changes in the DNA of growing cells. Unlike many adult cancers, which often result from years of environmental exposure or lifestyle factors, childhood cancers typically arise from genetic mutations that occur spontaneously during the body’s rapid growth and development.

This article shares what decades of research tell us about childhood cancer causes—not to replace your child’s medical team, but to provide context for the journey ahead. Every child’s cancer is unique, and your oncology team will provide guidance specific to your child’s situation.

How Does Childhood Cancer Develop?

Every cell in the human body contains DNA, and DNA is like an instruction manual that tells cells how to grow, divide, and function. Occasionally, errors occur when cells copy this DNA during division. Think of these like typos a person might make when copying a book by hand. Researchers often use this comparison because it captures how copying errors naturally occurs even in carefully controlled processes. In children, whose cells are dividing rapidly to support growth, these copying errors can sometimes lead to cancer.

Most of the time, the body’s natural repair systems catch and fix these errors. However, when multiple specific mutations accumulate in the same cell over time, that cell can begin growing out of control—and cancer develops.

Here’s the scale we’re talking about: During normal human cell division, between 100,000 to 1,000,000 DNA replication errors can occur each time a cell divides. The body’s proofreading systems correct nearly all of them, leaving only about 1 error per 10 billion letters of genetic code as a permanent mutation.

Highly Detailed Rendering of DNA

Of the mutations that do persist, research indicates that about 66% of cancer-driving mutations across all age groups are caused by these random, unavoidable copying errors—not by inherited genetics or environmental factors. 

This is why childhood cancer feels so senseless: it’s not punishment, it’s not karma, it’s not something you caused. It’s the statistical reality of copying billions of letters of genetic code millions of times during the rapid growth of childhood.

This understanding changes nothing about your child’s diagnosis, but it can change everything about how you carry it. You didn’t cause this. Embrace that knowledge so you can be fully present for the journey ahead.

Why Childhood Cancer is Different from Adult Cancer

The vast majority of cancer occurs in older adults, with over 50% of all cancers affecting people ages 70 and older. In contrast, childhood cancer is relatively rare, affecting 1 in 264 children and adolescents before age 20, and it develops for fundamentally different reasons than most adult cancers. According to the World Health Organization: “Unlike cancer in adults, most childhood cancers do not have a known cause.”

Different Cancer Types

Children typically develop cancers in different parts of the body than adults. While adults commonly develop carcinomas (cancers in tissues that line organs), children more frequently develop:

  • Leukemias (blood cancers)
  • Brain and central nervous system tumors
  • Lymphomas (lymphatic system cancers)
  • Sarcomas (bone and soft tissue cancers)
  • Neuroblastomas (nerve cell cancers)

For example, Wilms tumor is a type of cancer that affects the kidneys and is diagnosed on average in kids ages 3 to 4. It’s responsible for almost 5% of all childhood cancers and is specific to young children.

Different Causes

Adult cancers can develop after years or decades of exposure to risk factors like tobacco, alcohol, sun exposure, or poor diet. Childhood cancers don’t have time to develop this way—they emerge during the vulnerable period of rapid growth when cells are dividing frequently.

Different Response to Treatment

Because childhood cancers arise differently, they often respond better to treatment than adult cancers. According to the National Cancer Institute: “The cancer mortality rate—the number of deaths due to cancer per 100,000 people per year—among children and adolescents younger than 20 years declined by more than 50% from 1975 to 2022. It dropped from 5.1 per 100,000 children and adolescents in 1975 to 2.2 per 100,000 children and adolescents in 2022.”

While any cancer diagnosis is serious, children’s bodies are often more resilient and responsive to therapies, particularly when they are treated with pediatric treatment regimens.

A patient receiving treatment at Cure 4 The Kids Foundation

The Role of Genetics in Childhood Cancer

It’s crucial to understand the difference between:

Acquired genetic mutations: Genetic changes that occur randomly in a child’s cells after conception. These account for the vast majority of childhood cancers and are not passed down to future generations.

Inherited genetic mutations: Genetic changes passed down from parents that increase cancer risk. These are responsible for around 10% of childhood cancers.

Conditions That Increase Risk

Certain inherited conditions do increase a child’s risk of developing cancer, including:

  • Li-Fraumeni syndrome
  • Neurofibromatosis
  • Down syndrome
  • Beckwith-Wiedemann syndrome
  • Fanconi anemia

However, even with these conditions, cancer is not guaranteed. Conditions like the above simply increase susceptibility.

Known Risk Factors for Childhood Cancer

Unlike adult cancers, very few external risk factors have been definitively linked to childhood cancer. Research has identified only a handful:

Radiation Exposure

High-dose radiation exposure is one of the few confirmed environmental risk factors. This includes:

  • Previous radiation therapy for another cancer
  • Exposure to environmental sources such as radon (common in basements) or building materials
  • Exposure to atomic bomb radiation
  • Certain high-dose medical imaging

Standard medical X-rays and CT scans use much lower doses, and their benefits typically outweigh potential risks. It is crucial to note that, as emphasized by the National Cancer Institute, that CT scans can provide life-saving information for diagnosing illnesses in children and the absolute cancer risks associated with CT scans are small. For every 10,000 children undergoing today’s typical CT exposure (~8 mGy), roughly 1 to 2 might develop a blood cancer due to that exposure over their lifetime.

And although radiation exposure can potentially cause childhood cancer, it’s more likely that exposure during childhood might increase a child’s risk of cancer much later in life.

Some Chemotherapy Drugs

Children who have received certain chemotherapy drugs for a previous cancer have a slightly increased risk of developing a second cancer later.

Weakened Immune System

Children with compromised immune systems—whether from inherited conditions, HIV, or immunosuppressive medications—face elevated cancer risk.

Infusion/Ambulatory Center
A patient receiving treatment at Cure 4 The Kids Foundation

What Parents Cannot Control

This is perhaps the most important message for families: childhood cancer is almost never caused by anything parents did or didn’t do.

Decades of research has found no reliable connection between childhood cancer and:

  • Diet during pregnancy or childhood
  • Prenatal vitamins
  • Living near power lines
  • Cell phone use
  • Household chemicals used normally
  • Parenting practices
  • Physical activity levels

“Our hope is that every family who walks through our doors feels certain of one thing: childhood cancer is never a parent’s fault. It’s not the result of anything they did or didn’t do. When families are freed from that painful question of ‘why,’ they can redirect their energy toward what truly helps—the care, comfort, and courage their child needs.”

Dr. Joseph Lasky, Medical Director at Cure 4 The Kids Foundation

The randomness of childhood cancer can feel unfair…because it is. While this lack of control is difficult to accept, it’s important for families to release any misplaced guilt and focus instead on supporting their child and one another.

The Importance of Ongoing Research for Childhood Cancer

While we’ve made tremendous progress in treating childhood cancer, understanding its causes remains crucial for:

  • Developing better, more targeted therapies
  • Identifying children at higher risk
  • Potentially preventing some cases in the future
  • Reducing late effects of treatment

Organizations like Cure 4 The Kids Foundation and Coalition Against Childhood Cancer (CAC2) support vital research that advances our knowledge of childhood cancer biology and supports the development of new, cutting-edge treatment approaches.

Pediatric cancer research is gaining momentum with historic federal support. In a major win for childhood cancer research, the Childhood Cancer Data Initiative (CCDI) recently saw its annual budget doubled from $50 million to $100 million. This significant funding increase will accelerate efforts to collect, analyze, and share crucial data about childhood cancers, helping researchers worldwide identify patterns, understand causes, and develop more effective treatments faster. Learn more about this landmark funding increase and what it means for families.

Hope in Numbers: Childhood Cancer Survival Rates Continue to Rise

Thanks to vigorous, ongoing research, survival rates for childhood cancer have improved dramatically in recent decades. Mortality rates in children have dropped by 70%, falling from 6.3 deaths per 100,000 to just 1.9 during 2020-2022. Adolescents have seen similar progress with a 63% decline, from 7.2 to 2.7 deaths per 100,000.

The most striking improvements have been in leukemia treatment, where death rates have plummeted by 83% for children and 73% for adolescents. Today, childhood acute lymphocytic leukemia—the most common childhood cancer—achieves remission in 90–100% of cases. Remarkably, these gains came largely from refining and optimizing existing chemotherapy approaches rather than discovering entirely new drugs.

It’s worth noting that while both age groups have benefited from treatment advances, younger children have experienced greater improvements than adolescents. This gap stems from several factors, including biological differences in how tumors behave at different ages, varying rates of clinical trial participation, differences in treatment approaches, and how well patients tolerate and follow treatment protocols.

Cure 4 The Kids Foundation: Nevada’s Only Childhood Cancer and Rare Disease Treatment Center

Since our founding in 2007, Cure 4 The Kids Foundation has operated on a pioneering hybrid model that combines world-class clinical excellence with the heart of philanthropy. This means families receive the rigorous, cutting-edge treatments found in the nation’s top medical centers alongside genuine compassion and support—with one unwavering promise: no child with cancer is ever turned away, regardless of a family’s ability to pay.

As you’ve learned in this article, childhood cancer research is complex and ongoing. Every treatment advancement and improved outcome is possible because of donors who believe in our mission. Your contribution helps us provide exceptional care regardless of financial circumstances, advance critical research into childhood cancer causes and cures, and ensure every child has access to hope and healing.

MAKE A DONATION TODAY

About the Author: Annette Logan-Parker brings over 30 years of experience in pediatric oncology to her role as Founder and Chief Advocacy & Innovation Officer at Cure 4 The Kids Foundation. She has dedicated her career to improving outcomes for children with cancer and ensuring equitable access to cutting-edge treatments for all families.